DS Healthcare Group (OTCMKTS:DSKX – Get Free Report) and Haleon (NYSE:HLN – Get Free Report) are both consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.
Earnings & Valuation
This table compares DS Healthcare Group and Haleon”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
DS Healthcare Group | N/A | N/A | N/A | N/A | N/A |
Haleon | $11.24 billion | 3.90 | $1.30 billion | $0.34 | 28.50 |
Haleon has higher revenue and earnings than DS Healthcare Group.
Profitability
Net Margins | Return on Equity | Return on Assets | |
DS Healthcare Group | N/A | N/A | N/A |
Haleon | 10.85% | 14.76% | 7.32% |
Analyst Recommendations
This is a summary of recent ratings and recommmendations for DS Healthcare Group and Haleon, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
DS Healthcare Group | 0 | 0 | 0 | 0 | 0.00 |
Haleon | 0 | 1 | 4 | 1 | 3.00 |
Haleon has a consensus target price of $10.95, suggesting a potential upside of 13.00%. Given Haleon’s stronger consensus rating and higher possible upside, analysts plainly believe Haleon is more favorable than DS Healthcare Group.
Institutional and Insider Ownership
6.7% of Haleon shares are held by institutional investors. 19.4% of DS Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
Haleon beats DS Healthcare Group on 9 of the 10 factors compared between the two stocks.
About DS Healthcare Group
DS Healthcare Group, Inc. is a personal-care, product development and marketing company. The company develops and markets proprietary branded personal care products that address thinning hair conditions, skin care and other personal care needs. It research, develops and formulates its own products, consistent with its mission to provide products that make a meaningful difference in the lives of its customers. The company was founded on January 26, 2007 and is headquartered in Pompano Beach, FL.
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Receive News & Ratings for DS Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DS Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.